A Phase 1b, Open-Label, Multicenter Study to Evaluate the Safety and Preliminary Efficacy of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
Clinical Trial Grant
Awarded By
C4 Therapeutics, Inc
Start Date
June 29, 2026
End Date
June 19, 2031
Awarded By
C4 Therapeutics, Inc
Start Date
June 29, 2026
End Date
June 19, 2031